ArticleNature2025
Non-antibiotics disrupt colonization resistance against enteropathogens.
Abstract read
In one paragraph
Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed.
- The gut microbiota and host immunity synergistically orchestrate colonization resistance.Gut microbes · 2026Review
- Synergy between Enterobacteriaceae and diet mediates competition between dominant Bacteroidales in the human gut.Nature microbiology · 2026Article
- Microbiome ecology and antibiotic treatment failure: resistance spread, microbial competition and community engineering.Microbial genomics · 2026Review
- Anti-psychotic therapeutics modify gut microbial metabolism and modulate susceptibility to gastrointestinal infection in mice.bioRxiv : the preprint server for biology · 2026Article
- Drug-microbiome-host interactions: antimicrobial effects of non-antibiotic compounds.Nature reviews. Gastroenterology & hepatology · 2026Review
- The Nexus of Gut Microbiome, Microbial Metabolites, and Colonization Resistance Against Enteric Pathogens.Biomolecules · 2026Review
- Animal gut microbes and microbiomes in the 21st century and beyond.Science China. Life sciences · 2026Review
- Establishing and analyzing the Simplified Human Intestinal Microbiota (SIHUMI) as a versatile in vitro gut microbiome model with qPCR-based strain-level tracking.Nature protocols · 2026Review
- Metabolic strategies of Enterobacteriaceae gut colonization.Nature reviews. Microbiology · 2026Review
- Systematic profiling of growth interactions in human gut microbiome species.Nature communications · 2026Article
- Antibiotic-Driven Gut Microbiome Dysbiosis: Resistome Dynamics, Metabolic Disruption, and Paths to Restoration.Antibiotics (Basel, Switzerland) · 2026Review
- Deciphering the Implications ofPathogens (Basel, Switzerland) · 2026Review
- Antibiotic and Nonantibiotic Drugs Associated With Clostridioides difficile Infection Risk: a Pharmacopoeia-Wide Case-Cohort Study.The Journal of infectious diseases · 2026Article
- Identification of Association Between Mucus Microbiota and Gene Expression in the Gill of aAnimals : an open access journal from MDPI · 2026Article
- SET-M33 peptide as a selectiveMicrobiology spectrum · 2026Article
- The gut as a central hub for multi-organ crosstalk in aging.Cellular and molecular life sciences : CMLS · 2026Review
- Community-associated quinolone-resistant and extended-spectrum beta-lactamase-producingmSystems · 2026Article
- A Functional Metabolomics Framework to Track Microbiome Drug Metabolism.bioRxiv : the preprint server for biology · 2026Article
- Off to a good start: current gaps and priorities in early-life microbiome research.FEMS microbiology reviews · 2026Review
- Drug-microbiome interactions: What we know and why predictive translation remains elusive.Gut microbes reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Anne Grießhammer *Interfaculty Institute for Microbiology and Infection Medicine Tübingen, University of Tübingen, Tübingen, Germany.ORCID 0000-0002-1624-1365
Jacobo de la Cuesta-Zuluaga *Interfaculty Institute for Microbiology and Infection Medicine Tübingen, University of Tübingen, Tübingen, Germany.ORCID 0000-0002-7369-992X
Patrick MüllerInterfaculty Institute for Microbiology and Infection Medicine Tübingen, University of Tübingen, Tübingen, Germany.ORCID 0000-0003-3290-8251
Cordula GekelerInterfaculty Institute for Microbiology and Infection Medicine Tübingen, University of Tübingen, Tübingen, Germany.ORCID 0000-0001-9041-6672
Jan HomolakInterfaculty Institute for Microbiology and Infection Medicine Tübingen, University of Tübingen, Tübingen, Germany.ORCID 0000-0003-1508-3243
Hsuan ChangEuropean Molecular Biology Laboratory, Genome Biology, Heidelberg, Germany.
Katharina SchmittInterfaculty Institute for Microbiology and Infection Medicine Tübingen, University of Tübingen, Tübingen, Germany.
Chiara PlankerInterfaculty Institute for Microbiology and Infection Medicine Tübingen, University of Tübingen, Tübingen, Germany.
Verena SchmidtchenInterfaculty Institute for Microbiology and Infection Medicine Tübingen, University of Tübingen, Tübingen, Germany.ORCID 0009-0009-2740-9950
Suchira GallageM3 Research Center for Malignome, Metabolome and Microbiome, University Hospital Tübingen, Tübingen, Germany.
Erwin BohnInterfaculty Institute for Microbiology and Infection Medicine Tübingen, University of Tübingen, Tübingen, Germany.
Taylor H NguyenDepartment of Bioengineering, Stanford University, Stanford, CA, USA.ORCID 0000-0002-1288-8882
Jenny HetzerM3 Research Center for Malignome, Metabolome and Microbiome, University Hospital Tübingen, Tübingen, Germany.
Mathias HeikenwälderM3 Research Center for Malignome, Metabolome and Microbiome, University Hospital Tübingen, Tübingen, Germany.
Kerwyn Casey HuangDepartment of Bioengineering, Stanford University, Stanford, CA, USA.ORCID 0000-0002-8043-8138
Taiyeb ZahirInterfaculty Institute for Microbiology and Infection Medicine Tübingen, University of Tübingen, Tübingen, Germany.
Lisa MaierInterfaculty Institute for Microbiology and Infection Medicine Tübingen, University of Tübingen, Tübingen, Germany. l.maier@uni-tuebingen.de.ORCID 0000-0002-6473-4762
Funding
A universal pipeline for functional characterization of the human microbiota at a massive scaleRM1GM135102 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BUIE, CULLEN RICHARD, DEUTSCHBAUER, ADAM M · 2020 to 2024
$7.6MAntimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an AntibioticR01AI147023 · NIAID · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI RELMAN, DAVID A. · 2020 to 2024
$3.5MNIAID NIH HHS R01 AI147023NIGMS NIH HHS RM1 GM135102
Abstract
Non-antibiotic drugs can alter the composition of the gut microbiome
Indexed as
Gastrointestinal MicrobiomeSalmonella typhimuriumAnimalsAnti-Bacterial AgentsFecesFemaleGammaproteobacteriaHumansIntestinesMaleMiceMice, Inbred C57BLSalmonella InfectionsSymbiosisAnti-Bacterial Agents
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.